The role of octreotide in palliative care
- 31 August 1994
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 9 (6) , 406-411
- https://doi.org/10.1016/0885-3924(94)90178-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Octreotide in the Treatment of Disorders of the Gastrointestinal SystemClinical Drug Investigation, 1992
- Therapeutic efficacy of a somatostatin analogue (SMS 201–995) in active acromegalyJournal of Neurosurgery, 1986
- Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of SomatostatinScandinavian Journal of Gastroenterology, 1986
- Symptomatic Improvement with SMS 201-995in AcromegalyScandinavian Journal of Gastroenterology, 1986
- The Somatostatin Analog SMS 201-995 Induces Long-Acting Inhibition of Growth Hormone Secretion without Rebound Hypersecretion in Acromegalic Patients*Journal of Clinical Endocrinology & Metabolism, 1985
- SomatostatinNew England Journal of Medicine, 1983
- Somatostatin Decreases Diarrhea in Patients with the Short-Bowel SyndromeJournal of Clinical Gastroenterology, 1982
- Effects of somatostatin on the exocrine pancreas and the release of duodenal hormonesMetabolism, 1978
- GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN GASTROINTESTINAL AND PANCREATIC D CELLSThe Lancet, 1975
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974